FDA Inspection 866629 — Mission Pharmacal Company
The FDA completed an inspection of Mission Pharmacal Company on February 7, 2014 in Boerne, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 7, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Boerne, TX (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 3583 | 21 CFR 211.110(a) | Written in-process control procedures |